scholarly journals Participation Rate, Family Histories, Symptoms, and Incidence of Breast Cancer in the Screening Program for Breast Cancer in the Population Covered by Arak Health Centers

2021 ◽  
Vol 14 (2) ◽  
pp. 41-49
Author(s):  
Pegah Mohaghegh ◽  
Mahsa Farahani ◽  
Azam Moslemi ◽  
Farzane Ahmadi ◽  
Javad Nazari ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Screening Program ◽  
Participation Rate ◽  
Health Centers ◽  
Family Histories

Coorscreen: A Low-Cost, on-Site Mammography Screening Program

1996 ◽  
Vol 10 (5) ◽  
pp. 364-370 ◽  
Author(s):  
Mary Greenwood ◽  
Joanne Henritze
Keyword(s):  
Breast Cancer ◽  
Early Detection ◽  
Malignant Disease ◽  
Screening Program ◽  
Low Cost ◽  
Cost Savings ◽  
Participation Rate ◽  
Program Cost ◽  
Mammography Screening Program ◽  
Screening And Prevention

Setting. Coors Brewing Company is a self-insured corporation of 10,600 employees located in Golden, Colorado. Management has long believed in the value of a healthy workforce and has instituted ongoing health and wellness programming since 1981. Program design. Coorscreen was started in September 1985 to create an ongoing awareness of breast cancer screening and prevention for all female employees, spouses, and retirees and to lower the health care costs for the company through early detection of breast cancer. Program impact. From 1985 through 1993, 12,210 mammograms were completed on 3729 employees, spouses, and retirees. The participation rate was 83%. Forty-seven malignant conditions were confirmed during the first 8 years. Pathology reports confirmed 43 early detections (10 employees) and four late detections (two employees). The 10 cases of malignant disease detected early among employees cost an average of $12,388 in terms of direct medical costs, short-term disability, temporary replacement, and ongoing benefits. The two cases detected late among employees cost an average of $143,398. Among spouses, cases of malignant disease detected late have cost an average of $69,230 more than cases detected early. On the basis of early detection for 10 employees and 26 spouses, the total savings are estimated to be $3,110,000. Discussion. The Coorscreen program cost savings for the first 8 years were $3,110,080 because of the lower cost of early versus late detection. Total screening and procedural costs to the company have equaled $668,690. Thus the company has realized a total cost savings of $2,441,190.

scholarly journals Participation Rate, Risk Factors, and Incidence of Colorectal Cancer in the Screening Program Among the Population Covered by the Health Centers in Arak, Iran

2021 ◽  
Vol 14 (7) ◽  
Author(s):  
Pegah Mohaghegh ◽  
Farzane Ahmadi ◽  
Mahjabin Shiravandi ◽  
Javad Nazari
Keyword(s):  
Colorectal Cancer ◽  
Risk Factors ◽  
Incidence Rate ◽  
Screening Program ◽  
Participation Rate ◽  
Health Centers ◽  
Crude Incidence Rate ◽  
Crude Incidence ◽  
Crc Screening ◽  
Rate Risk

Background: Colorectal cancer (CRC) is among the most common and preventable cancers, the incidence and risk factors of which are different in various populations. Objectives: The present study aims at assessing incidence rate, risk factors, and symptoms of CRC among the populations aged 50 to 70 years old covered by the health centers in Arak, as well as evaluating participation rate in the CRC screening program. Methods: The present cross-sectional study was conducted from 2016 to 2019 among all of the individuals aged 50 to 70 years old, who were referred to rural, urban, and suburban health centers in Arak for CRC screening, and their data were recorded in the Sib system. The participation rate, risk factors (family and individual history of CRC, colorectal adenoma, and inflammatory bowel disease), symptoms (lower gastrointestinal bleeding, constipation with or without diarrhea, and weight loss), and crude incidence rate of CRC were calculated in the age range. Results: The mean (SD) age of the CRC was 59.72 (5.56) years. In addition, the individuals’ participation rate in the program was about 44.2%, which was more among women (55.5%) and villagers (93.7%). Most subjects complained of constipation in the last month and CRC family history. The CRC crude incidence rates were 35.93 (95% CI: 25.55 - 50.54), 40.96 (95% CI: 29.81 - 56.29), 43.76 (95% CI: 32.22 - 59.43), and 52.84 (95% CI: 40.05 - 69.71) per 100000 individuals during 2016, 2017, 2018, and 2019, respectively. Conclusions: The participation rate in the CRC screening program was low, and the trend of the cancer crude incidence rate increased among the populations aged 50 to 70 years. Finally, informing about the recognition of the risk factors and symptoms of cancer, as well as the timely referral for screening was considered essential.

Outcomes of an organized breast cancer screening program over the past 15 years.

2012 ◽  
Vol 30 (27_suppl) ◽  
pp. 14-14
Author(s):  
Rasika Rajapakshe ◽  
Brent Parker ◽  
Cynthia Araujo ◽  
Christina Chu ◽  
Christine Wilson ◽  
...  
Keyword(s):  
Breast Cancer ◽  
British Columbia ◽  
Cancer Detection ◽  
Detection Rate ◽  
Screening Program ◽  
Participation Rate ◽  
Screening Mammography ◽  
Cancer Detection Rate ◽  
Stable Range ◽  
The Past

14 Background: Founded in 1988, The Screening Mammography Program of British Columbia (SMPBC) is a large, and stable screening program and a formal review of its effectiveness provides suggestions for further improvements. The purpose of this study is to quantify and report trends of the SMPBC and to assess if there have been any major changes in outcomes over the past fifteen years as this program has matured. Methods: A retrospective review of the SMPBC was performed by extracting data from the past 15 years from the SMPBC Annual Reports. The changes and trends in percentage of eligible population screened/participation rate, number of screening exams and number of first screens performed, overall cancer detection rate, and DCIS detection rate was extracted and reported. Furthermore, cost analysis data was extracted, and adjusted to compensate for inflation using The Bank of Canada Inflation Calculator, which bases its calculations from the Canadian Consumer Price Index (CPI) from Statistics Canada. Results: Over the past 15 years, the total number of exams provided per year has almost doubled from 166,746 in 1996 to 303,157 in 2010, and this increase accommodates the overall and aging growth of the BC population. An increasing participation rate is seen from 1999-2009 for women from rural sites and traditionally underserved areas of British Columbia, while the overall participation rate over this time period remains stable (range 48%-51%). The cancer detection rate also remains stable (range: 3.4-4.5 cases per 1000 screens). After adjusting for inflation, a 12.6% increase in the cost per screen from 1995-2009 is observed. This increase is multifactorial and includes an increase in operating costs central services and physician reading fees. Conclusions: The province of British Columbia has consistently had the lowest rates of breast cancer related mortality in Canada, and this may be, in part, because of the long term stability of the BC Screening Mammography Program. Our report suggests that the SMPBC has been effective in accommodating the growing aging population, although there is still room for improvement, as a target participation of 70% is considered the standard to effectively reduce mortality through screening.

scholarly journals A review of screening mammography participation and utilization in Canada

2011 ◽  
Vol 31 (4) ◽  
pp. 152-156 ◽  
Author(s):  
GP Doyle ◽  
D Major ◽  
C Chu ◽  
A Stankiewicz ◽  
ML Harrison ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Screening ◽  
Breast Cancer Screening ◽  
Screening Program ◽  
Participation Rate ◽  
Screening Mammography ◽  
Current Approach ◽  
Alternative Methods ◽  
Utilization Rate ◽  
Important Indicator

Introduction Participation rate is an important indicator for a screening program’s effectiveness; however, the current approach to measuring participation rate in Canada is not comparable with other countries. The objective of this study is to review the measurement of screening mammography participation in Canada, make international comparisons, and to propose alternative methods. Methods Canadian breast cancer screening program data for women aged 50 to 69 years screened between 2004 and 2006 were extracted from the Canadian Breast Cancer Screening Database (CBCSD). The fee-for-services (FSS) mammography data (opportunistic screening mammography) were obtained from the provincial ministries of health. Both screening mammography program participation and utilization were examined over 24 and 30 months. Results Canada’s screening participation rate increases from 39.4% for a 24-month cut-off to 43.6% for a 30-month cut-off. The 24-month mammography utilization rate is 63.1% in Canada, and the 30-month utilization rate is 70.4%. Conclusion Due to the differences in health service delivery among Canadian provinces, both programmatic participation and overall utilization of mammography at 24 months and 30 months should be monitored.

scholarly journals Organized colorectal cancer screening in Serbia - the first round within 2013-2014

2016 ◽  
Vol 73 (4) ◽  
pp. 360-367 ◽  
Author(s):  
Dusica Bankovic-Lazarevic ◽  
Zoran Krivokapic ◽  
Goran Barisic ◽  
Verica Jovanovic ◽  
Dragan Ilic ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Cancer Screening ◽  
Colorectal Cancer Screening ◽  
Screening Program ◽  
Participation Rate ◽  
Target Population ◽  
Health Centers ◽  
Expected Improvement ◽  
Fecal Occult Blood ◽  
Primary Health

Background/Aim. The National Organized Colorectal Cancer Screening Program was conducted in the Republic of Serbia during 2013-2014 covering the population of both genders, aged 50 to 74 years, in 28 municipalities out of 180, with the target population of 651,445 people. This organized colorectal cancer screening aims to reduce mortality from colorectal cancer in the target population. The aim of this study was to show the results of organized screening for colorectal cancer during the first biannual round in Serbia. Methods. General practitioners from the primary health centers, invited target population by letters and by phone to perform immunochemical fecal occult blood test. Persons with a positive test results were referred to the colonoscopy. The database of health insurance and other citizens of the target population was used for invitation for screening in primary health centers. Descriptive statistical analysis of the results in organized colorectal cancer screening in the first round was performed for the key screening indicators. Results. In the first round, a total of 99,592 persons were invited. The participation rate was 62.5%. Colonoscopy was performed in 1,554 persons. Adenomas were found in 586 persons (0.9% of all the tested), e.g. 37.7 % of all colonoscopied. In 129 persons colorectal cancer was diagnosed (0.2% of all the tested), e.g. 8.3% of all the colonoscopied. In the left half of the colon (rectum, sigmoid and descending colon) there were 70.4% diagnosed polyps and 77.3% carcinomas, while 29.6% of polyps and 22.7% carcinomas were found in the proximal parts of the colon. Conclusion. In the first round of the organized colorectal cancer screening in Serbia the participation rate of the targeted population was high and gave encouraging result. It was expected that in the forthcoming rounds even higher coverage of the target population would be accomplished. A positive predictive value of the completed colonoscopies showed that further work on observing the stages of diagnosed adenomas and carcinomas would reach the goals of the expected improvement in early detection of colorectal cancer in Serbia.

Cost-Effectiveness of Breast Cancer Screening in Spain

1996 ◽  
Vol 12 (1) ◽  
pp. 146-150 ◽  
Author(s):  
Pedro Plans ◽  
Laura Casademont ◽  
Luis Salleras
Keyword(s):  
Breast Cancer ◽  
Cost Effectiveness ◽  
Cancer Screening ◽  
Breast Cancer Screening ◽  
Screening Program ◽  
Participation Rate ◽  
Breast Cancers ◽  
Cost Effectiveness Ratio ◽  
Program Costs ◽  
The Cost

AbstractIn the last several years, the development of an effective breast cancer screening procedure has increased the possibility of the early detection of this cancer. We investigated the cost-effectiveness of a breast cancer screening program to screen 100,000 women 50–64 years of age in Catalonia (Spain). The cost-effectiveness ratio was measured in terms of the cost per cancer detected comparing program costs to the estimated number of cancers detected. We assumed a participation rate, sensitivity, and specificity of 70%, 92%, and 94%, respectively, and that 0.36 breast cancers could be detected per 100 women screened. We estimated a total cost of $2.1 million with $1.4 million for the mammographic stage and $0.7 million for the detection of the true positive mammographic results. The cost per woman screened was $30. We estimated that 252 cases of breast cancer could be detected with the program. The cost-effectiveness ratio obtained in this study was $8,424 per cancer detected. Sensitivity analysis has shown that cost-effectiveness results are sensitive to the variations in the following variables: specificity, cancer detection rate, and screening costs. In planning preventive programs, breast cancer screening should be considered one of the priorities.

scholarly journals Overview of Ten Years (2007-2016) Cervical and Breast Cancer Screening Program in Indonesia

2018 ◽  
Vol 4 (Supplement 2) ◽  
pp. 51s-51s
Author(s):  
M. Wahidin
Keyword(s):  
Breast Cancer ◽  
Cervical Cancer ◽  
Cancer Screening ◽  
Breast Cancer Screening ◽  
Screening Program ◽  
Health Centers ◽  
National Program ◽  
Primary Health ◽  
Breast Cancer Screening Program ◽  
Cancer Screening Program

Background: Cervical and breast cancer screening have been national program in Indonesia since 2007. The Ministry of Health of Indonesia in collaboration with provincial and district government developed and implemented the program. Method of cervical cancer screening was visual inspection with acetic acid (VIA) or Papanicolaou test and early treatment with cryotherapy for VIA positive. Meanwhile, method of breast cancer screening was clinical breast examination (CBE). After 10 years of implementation, it need to know how the program was conducted and what the results are. Aim: The study was aimed to know activities and results of cervical and breast cancer screening in 10 years (2007-2016). Methods: Design of the study was descriptive study through literature and data review from related data and information sources. Secondary data were collected from Directorate of Non Communicable Disease Control, Ministry of Health, Directorate of Primary Health Service, and professionals. The study was conducted in November-December 2017. Results: Program of cervical and breast cancer screening was started by pilot project in 2007 by 6 districts of 6 provinces in Indonesia: Jakarta, West Java, Central Java, Jogjakarta, North Sumatera, and South Sulawesi. By April 21, 2008 the program was launched as national program by Indonesian First Lady. Then, the program was developed in all province in Indonesia. Activities conducted to develop the program were training of trainers at national level, trainings at district level, socialization to community, providing services of the screening, monitoring, and evaluation. The screening was provided by trained health care provider (general practitioner and midwife) in primary health centers with referral system to district/municipality hospitals. Target of the program was women aged 30-50 years. Since 2007 till 2016, the program was running in all 34 (100%) provinces, 393 out of 514 districts/municipalities (76%), 3706 out of 9813 primary health centers (38%). Clinical trainers of the program were 366 persons consists of OB/GYN oncologist, OB/GYN surgeon oncologist, surgeon, general practitioners, and midwives. Providers of screening were 8526 persons consists of 2783 general practitioners, and 5743 midwives (2.3 providers per primary health center). There were 375 cryotherapy set for early treatment of VIA positive. The result of ten years cervical and breast cancer screening showed that 1,925,943 women have been screened or 5.15% of target 37.4 million women. It was still lower than target of 20% in 2016. VIA positive 73,453 women (3.8%), suspect of cervical cancer 1739 (1 per 1000), lump/tumor in the breast 4030 women (2.1 per 1000). Conclusion: Cervical and breast cancer screening program was running in all provinces and majority of district/municipalities in Indonesia with adequate human resources, but the coverage of the screening was still low.

scholarly journals Breast Cancer Screening Strategies and Indicators in Iran, A Systematic Review

2020 ◽  
Author(s):  
Zahra Omidi ◽  
Maryam Koosha ◽  
Najmeh Nazeri ◽  
Nasim Khosravi ◽  
Shahpar Haghighat
Keyword(s):  
Breast Cancer ◽  
Systematic Review ◽  
Cancer Screening ◽  
Breast Cancer Screening ◽  
Screening Program ◽  
National Level ◽  
Participation Rate ◽  
Educational Interventions ◽  
Recall Rate ◽  
Educational Method

Abstract BackgroundA lot of individual health behaviors and multi-faceted approached have been introduced for breast cancer early diagnosis and prevention. This systematic review aimed to investigate the status of Breast cancer preventive behaviors and screening indicators among Iranian women.MethodsIn this study, two reviewers included English and Persian articles about breast cancer screening modalities and its indicators in Iran from January 2005 to 2020. English electronic databases of Web of Science, PubMed and Scopus and Persian databases of SID and IranMedex were used. The critical information of articles was extracted and classified to different categories according to the studied outcomes. ResultsA total of 246 articles were assessed which 129 of them were excluded and 114 studies were processed for further evaluation. Performing BSE, CBE, and Mammo in Iranian women had been reported 0- 79.4%, 4.1%-41.1%, and 1.3%-45%, respectively. All of the educational interventions had increased the knowledge, attitude and practice of participants in performing the screening behaviors. The most important screening indicators included participation rate (3.8% to 16.8%), detection rate (0.23 to 8.5 per 1000), abnormal call rate (28.77% to 33%), and recall rate (24.7%).ConclusionThis systematic review demonstrated a lot of heterogeneity in population and design of researches about breast cancer early detection in Iran. The necessity of a cost-effective screening program, presenting a proper educational method for increasing women's awareness and estimating screening indices can be the priorities of future researches. Establishing big studies at the national level in a standard framework are advised

scholarly journals Kuwait National Mammography Screening Program: outcomes of 5 years of screening in Kuwaiti women

2021 ◽  
Vol 41 (5) ◽  
pp. 257-267
Author(s):  
Hanaa Abdulla Alkhawari ◽  
Akram Mahmoud Asbeutah ◽  
Abdullah Abdulaziz Almajran ◽  
Latifa Abdullah AlKandari
Keyword(s):  
Breast Cancer ◽  
Early Detection ◽  
Mammography Screening ◽  
Ductal Carcinoma ◽  
Screening Program ◽  
Retention Rate ◽  
Lobular Carcinoma ◽  
Participation Rate ◽  
Program Outcomes ◽  
Mammography Screening Program

BACKGROUND: Breast cancer is the most common malignancy among women in Kuwait, representing 39.8% of all female cancer cases. OBJECTIVES: Report the data of the Kuwait National Mammography Screening Program (KNMSP) for a 5-year period. DESIGN: Prospective data collection. SETTING: Population-based screening. SUBJECTS AND METHODS: We included mammography screens done for Kuwaiti women (age 40 years and older) who attended the KNMSP from 2014 to 2019 to screen for breast cancer. A full-field digital mammography system was used to acquire the mammographic images in craniocaudal and mediolateral oblique projections. Independent double-blind reading of the mammograms was performed by two radiologists. MAIN OUTCOME MEASURE: Early detection of breast cancer. SAMPLE SIZE: 14 773 asymptomatic women met inclusion criteria (mean [SD] age, 51.8 (8.2). RESULTS: Lesions were detected in 551 women (3.7%). These included 233 malignant lesions (233/551, 42.3%), 57 high-risk lesions (10.3%) and 261 benign lesions (47.4%). The participation rate was 7.8% of the target population of women 40–69 years of age. The majority of breast cancer cases were reported in the age group 45–49 years (23.2%). The KNMSP study recall rate for 5 consecutive years was in a range of 11.9–16.5% (mean, 14.3%). The detection rate of ductal/lobular carcinoma in situ and invasive breast cancer were 2.5 and 13.6 per 1000 screened women, respectively. Invasive ductal carcinoma was the most common type. Only 4314 women followed up within 12–15 months of the first mammography for a retention rate of 29.2%. CONCLUSIONS: Screening mammography improves early detection of breast cancer in women older than 40 years but poor participation is a limitation. We are aiming to increase the participation rate to 70% of the population. LIMITATIONS: Lack of participation by women. CONFLICT OF INTEREST: None.

scholarly journals ARE WE DOING ENOUGH IN PROMOTING BREAST CANCER SCREENING: AN EVALUATION OF MALAYSIA BREAST CANCER SCREENING PROGRAM

2021 ◽  
Vol 21 (3) ◽  
pp. 230-239
Author(s):  
Zakiah Mohd Said ◽  
Rosnah Sutan
Keyword(s):  
Breast Cancer ◽  
Cancer Screening ◽  
Breast Cancer Screening ◽  
Screening Program ◽  
Cancer Control ◽  
Participation Rate ◽  
Clinical Breast Examination ◽  
Cancer Screening Program ◽  
Breast Examination ◽  
Clinical Breast

Breast cancer is the most common cancer affecting  women globally. Several ways of breast cancer screening tools are available. This study aims to evaluate Malaysia's breast cancer screening program using the national database based on participation and performance indicators for the past five years. A retrospective cumulative analysis of clinical breast examination and mammogram screening services were performed using the national dataset of 2016-2020 obtained from the Health Informatics Centres, Ministry of Health Malaysia. The performance indicator represents the percentage of breast abnormality detected during clinical breast examination and the proportion of confirmed cancer through mammogram screening.  A reduction in the participation rate for clinical breast examination was noted from 2016 (25.8%) to 2020(25.1%). However, a high participation rate in 2019 (29.1%) was noted following active health promotion intervention. The rate of high-risk women who underwent mammogram screening fluctuated by years according to active breast awareness campaign. The average rate of confirmed breast cancer annually was 0.7% and was noted highest in 2020 (1.17%).  Improving early diagnosis is an eminent strategy for cancer control in all settings, including strengthening health systems and providing universal health coverage. Successful breast cancer prevention and control programs require intersectoral planning and active community participation. Ensuring sustainability and accessibility of breast cancer screening programs is highly needed. Fostering good collaborative multiagency partnership and community participation for the cancer control program urges an innovative approach through a policy formulation.

Sign in / Sign up

Export Citation Format

Share Document